Brief: Spectracure Has Been Approved Grant From EU Of EUR 125,000
07/06/2022 13:59
June 7 (Reuters) - SpectraCure AB (publ) SPEC.ST :
* HAS BEEN APPROVED A GRANT FROM EU OF EUR 125,000 FOR AN INDUSTRIALIZATION PROJECT FOR
COMPANY'S
PRODUCT, FOR TREATMENT OF PROSTATE CANCER WITH INTERSTITIAL PHOTODYNAMIC TREATMENT (PDT)
* GRANT IS APPROVED AS PART OF MEDPHAB, A SO-CALLED "PILOT PRODUCTION LINE", FINANCED
THROUGH
GRANTS FROM EU'S HORIZON 2020 PROGRAM
* PROJECT'S TOTAL BUDGET IS APPROXIMATELY EUR 166,000, OF WHICH EUR 125,000 ARE GRANTS AND
REST IS
CONTRIBUTED BY SPECTRACURE
* PROJECT IS PLANNED TO BE COMPLETED IN 2022
Source text for Eikon: ID:nWkr3ZPmcw
Further company coverage: SPEC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))